维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="OSHAUGHNESSY J"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Single-agent capecitabine: a reference treatment for taxane-pretreated metastatic breast cancer显示文摘	Seidman AD Oshaughnessy J Misset JL	2002	Oncologist2002，17，6：	1
2	Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 ( PARP-1 ) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): results of a randomized phase II trial 显示文摘	OSHAUGHNESSY J OSBORNE C PIPPEN J	2009	J Clin Oncol2009，27，6：	1
3	Randomized, open-labelled, phase Ⅱ trial of orai capecitabine (Xeloda) vs a reference arm of intravenous CMF(cyclophosphamide, methotrexate and 5-fluorouracil)as first-line therapy for advanced/metastatic breast cancer显示文摘	Oshaughnessy JA Blum J Moiseyenko V	2001	Ann Oncol2001，12，9：	1
4	A retrospective evaluation of the impact of dose reduction in patients treated with Xeloda (capecitabine)显示文摘	Oshaughnessy J Blum J	2000	Proc Am Soc Clin Oncol2000，19，：	1
5	Superior survival with capeeitabine plus docetaxel combination therapy in anthracycline-pretreated patients with ad- vanced breast cancer: Phase III trial results 显示文摘	OShaughnessy J Miles D Vukelja S	2002	J Clin Oncol2002，20，12：	1
6	Expression of cytochrome P450 17 alpha-hydroxylase/C17-20 lyase in the fetal rat testis is reduced by maternal exposure to exogenous estrogens 显示文摘	Majdic G Sharpe R M Oshaughnessy P J	1996	Endocrinology1996，137，：	1
7	Random- ized open label, phase II trial of oral capecitabine VSA reference am of intravenous CMF as first line therapy for advanced breast cancer 显示文摘	Oshaughnessy J A Blum J M Moiseyenko V	2001	Ann Oncol2001，12，9：	1
8	Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success 显示文摘	Hiby SE Walker J J Oshaughnessy KM	2004	J Exp Med2004，200，8：	1
9	Identifying key determinants for new product introductions and firm performance in small service firms显示文摘	VERMEULEN PATRICK A M DE JONG JEROEN P J OSHAUGHNESSY K C	2005	Service Industries Journal2005，25，5：	1
10	Preliminary results of a randomized phase Ⅱ study of weekly irinotecan/carboplatin with or without cetuximab in patients with metastatic breast cancer 显示文摘	OSHAUGHNESSY J WECKSTEIN D J VUKELJA S J	2007	Breast Cancer Res Treat2007，106，1：	1
11	neural stem cell differentiation in a cell - collagen - bioreactor culture system 显示文摘	Lin H J Oshaughnessy TJ Kelly J	2004	Brain Res Dev Brain Res2004，153，2：	1
12	Effects of hypoxia on fetal rat brain metabolsm studied in utero by 31P-NMR spectroscopy显示文摘	Oshaughnessy CT Lythgoe D J Butcher S J	1991	Brain Res1991，551，12：	1
13	Iniparib plus chemotherapy in metastatic triple-negative breast cancer显示文摘	OShaughnessy J Osborne C Pippen JE	2011	N Engl J Med2011，364，3：	1
14	Iniparib plus chem- otherapy in metastatic triple -negative breast cancer显示文摘	OShaughnessy J Osborne C Pippen JE	2011	N Eng J Med2011，364，3：	1
15	Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer Ⅲ trial results显示文摘	Miles D Vuklja S	2002	J Clin Oncol2002，20，：	1
16	Involvement of two isoforms of SNAP-25 in the expression of long-term potentiation in the rat hippoeampus显示文摘	Roberts L A Morris B J Oshaughnessy C T	1998	Neurore Port1998，9，1：	1
17	Iniparib plus c, hem- otherapy in metastatie triple-negative breast cancer 显示文摘	OShaughnessy J Osborne C Pippen JE	2011	N Engl J Med2011，364，3：	1
18	IL-10 and TGF- beta induce alloreactive CD4^+ CD25-T cells to acquire regulatory cell function显示文摘	CHEN Z M OSHAUGHNESSY M J GRAMAGLIA I	2003	Blood2003，101，12：	1
19	UGT1A1 promoter genotype correlates with SN - 38 pharmacokinetics, but not severe toxicity in patients receiving low - dose irinotecan显示文摘	Stewart C F Paaetta J C OShaughnessy M A	2007	J Clin Onco12007，25，：	1
20	Superior survival with capecitabine plus docetaxel combination therapy in anthracycline - pretreated patients with advanced breast cancer: Phase Ⅲ trial re- sults显示文摘	OShaughnessy J Miles D Vukelja S	2002	J Clin Oncol2002，20，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示